Latest filing published 18 Jan 2018 for CanniMed Therapeutics Inc..
No signal scores available.
Douglas Banzet appears in our data through filings on CanniMed Therapeutics Inc. shares, published by SEDI. The record holds 4 filings, for trades running from 29 December 2016 to 15 January 2018.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 18 January 2018: a transaction, in CanniMed Therapeutics Inc. Between a trade and the moment it shows up on SEDI, the median delay is 6 days. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations